These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28618756)

  • 21. The protective effect of the large-scale use of PHKC rabies vaccine in humans in China.
    Lin FT
    Bull World Health Organ; 1990; 68(4):449-54. PubMed ID: 2208558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Freeze-drying of live virus vaccines: A review.
    Hansen LJJ; Daoussi R; Vervaet C; Remon JP; De Beer TRM
    Vaccine; 2015 Oct; 33(42):5507-5519. PubMed ID: 26364685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intake and stability of a rabies vaccine.
    Maciulskis P; Lukauskas K; Milius J; Jacevicius E; Kiudulas V; Jokimas J; Pockevicius A
    Dev Biol (Basel); 2008; 131():449-59. PubMed ID: 18634507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of collapse lyophilized influenza vaccine formulations.
    Anamur C; Winter G; Engert J
    Int J Pharm; 2015 Apr; 483(1-2):131-41. PubMed ID: 25660049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A thermostable messenger RNA based vaccine against rabies.
    Stitz L; Vogel A; Schnee M; Voss D; Rauch S; Mutzke T; Ketterer T; Kramps T; Petsch B
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006108. PubMed ID: 29216187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine.
    Asgary V; Shoari A; Baghbani-Arani F; Sadat Shandiz SA; Khosravy MS; Janani A; Bigdeli R; Bashar R; Cohan RA
    Int J Nanomedicine; 2016; 11():3597-605. PubMed ID: 27536101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of an inactivated rabies vaccine in primary dog kidney cells.
    van Wezel AL; van Steenis G
    Dev Biol Stand; 1978; 40():69-75. PubMed ID: 98375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitive in vitro assay for the detection of residual viable rabies virus in inactivated rabies vaccines.
    Takayama-Ito M; Nakamichi K; Kinoshita H; Kakiuchi S; Kurane I; Saijo M; Lim CK
    Biologicals; 2014 Jan; 42(1):42-7. PubMed ID: 24321529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine.
    Asgary V; Shoari A; Afshar Moayad M; Shafiee Ardestani M; Bigdeli R; Ghazizadeh L; Khosravy MS; Panahnejad E; Janani A; Bashar R; Abedi M; Ahangari Cohan R
    Viral Immunol; 2018; 31(1):47-54. PubMed ID: 29328884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A time-resolved fluoroimmunoassay for the quantitation of rabies virus nucleoprotein in the rabies vaccine.
    Lin G; Huang H; Liu T; He C; Liu J; Chen S; Hou J; Ren Z; Dong W; Wu Y
    J Virol Methods; 2014 Sep; 206():89-94. PubMed ID: 24928690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heat stability of a lyophilized inactivated anti-rabies-vaccine].
    Jaeger O; Barth R
    Zentralbl Bakteriol Orig; 1969 May; 210(1):135-9. PubMed ID: 5361074
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
    Rupprecht CE; Briggs D; Brown CM; Franka R; Katz SL; Kerr HD; Lett SM; Levis R; Meltzer MI; Schaffner W; Cieslak PR;
    MMWR Recomm Rep; 2010 Mar; 59(RR-2):1-9. PubMed ID: 20300058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of dogs against death from experimental rabies by postexposure administration of rabies vaccine and hyperimmune globulin (human).
    Cho HC; Lawson KF
    Can J Vet Res; 1989 Oct; 53(4):434-7. PubMed ID: 2590870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation approach for the development of a stable, lyophilized formaldehyde-containing vaccine.
    Clausi A; Chouvenc P
    Eur J Pharm Biopharm; 2013 Oct; 85(2):272-8. PubMed ID: 23673385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response to purified chick embryo cell culture rabies vaccine manufactured in India.
    Natarajan M; Mukundan P; John TJ
    Indian J Med Res; 1992 Mar; 95():51-3. PubMed ID: 1601469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3).
    Shen CF; Lanthier S; Jacob D; Montes J; Beath A; Beresford A; Kamen A
    Vaccine; 2012 Jan; 30(2):300-6. PubMed ID: 22079076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development.
    Zhu S; Li H; Wang C; Luo F; Guo C
    J Neurovirol; 2015 Aug; 21(4):335-45. PubMed ID: 25994916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIMULTANEOUS GROWTH OF RABIES AND CANINE DISTEMPER VIRUSES IN CHICK EMBRYOS.
    CHANG JC
    Can J Comp Med Vet Sci; 1965 Feb; 29(2):38-41. PubMed ID: 14290942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of attenuated live virus rabies vaccine in baits targeted to wild foxes under operational conditions.
    Lawson KF; Bachmann P
    Can Vet J; 2001 May; 42(5):368-74. PubMed ID: 11360859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rabies: a new look at an old disease.
    Smith JS; Seidel HD
    Prog Med Virol; 1993; 40():82-106. PubMed ID: 8438079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.